If you do have a spike in weight, dont panic, Dr

Here's a concise breakdown of the major drug classes used in Type 2 Diabetes Mellitus: 1 Biguanides (e.g., Metformin) Decreases hepatic glucose production, improves insulin sensitivity No hypoglycemia risk | First-line therapy for T2DM 2 Sulfonylureas (Gliclazide, Glimepiride, Glipizide) Stimulate insulin release from pancreatic -cells Effective but carry hypoglycemia risk use cautiously in elderly/renal impairment 3 DPP-4 Inhibitors (Sitagliptin, Vildagliptin, Linagliptin) Increase incretin levels, boost insulin secretion Weight neutral, well tolerated 4 SGLT2 Inhibitors (Dapagliflozin, Empagliflozin, Canagliflozin) Promote glucose excretion via urine Cardio-renal protective a major shift in modern diabetes care 5 GLP-1 Receptor Agonists (Liraglutide, Semaglutide, Dulaglutide) Glucose-dependent insulin secretion, promotes satiety Excellent for weight loss in obese T2DM patients 6 Thiazolidinediones (Pioglitazone) Improves insulin sensitivity via PPAR- activation Caution: fluid retention, avoid in heart failure 7 Alpha-Glucosidase Inhibitors (Acarbose, Miglitol) Delay carbohydrate absorption, reduce postprandial spikes Take with the first bite of a meal 8 Insulin Rapid, short, intermediate & long-acting formulations Essential in Type 1 DM and advanced Type 2 DM Key takeaway: Therapy must be individualized based on patient comorbidities, hypoglycemia risk, weight goals, and cardiovascular/renal status

Fonseca T, Clegg J, Caputo G, Norrbacka K, Dilla T, Alvarez M
Users with gallbladder concerns Rapid weight loss from any cause increases the risk of gallstone formation
Retatrutide is being studied because researchers are evaluating whether adding glucagon receptor activity may further influence energy expenditure and weight reduction